Literature DB >> 7982725

Sex difference in the serostatus of adults to the Epstein-Barr virus.

H J Wagner1, M Hornef, H M Teichert, H Kirchner.   

Abstract

A total of 1047 adults, aged between 18 and 90 years, including blood donors and surgical patients of the Medical University of Lübeck in Germany, were screened for IgG antibodies to the Epstein-Barr Virus, either by standard indirect immunofluorescence or by a novel enzyme-linked immunosorbent assay (Enzygnost Anti-EBV/IgG, Behring, Marburg, Germany). There was a significant sex difference in the serostatus to the Epstein-Barr virus in adults. Male adults were more likely than females (p < 1%) to be EBV-seronegative. The same trend was seen in both a group of 713 blood donors and 334 surgical patients and when different test methods were used. However, this sex difference was not shown in the sera of 86 pediatric patients of the Medical University of Lübeck tested by indirect immunofluorescence for IgG antibodies to the Epstein-Barr virus. Furthermore, titers of IgG antibodies to Epstein-Barr virus specific antigens of female adults, obtained by the enzyme-linked immunosorbent assay (Enzygnost Anti-EBV/IgG), had significantly higher median values than male adults (p < 5%).

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7982725     DOI: 10.1016/S0171-2985(11)80613-3

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  9 in total

Review 1.  Sexual dimorphism in innate immune responses to infectious organisms.

Authors:  Ian Marriott; Yvette M Huet-Hudson
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

2.  Herpesvirus reactivation and socioeconomic position: a community-based study.

Authors:  Raymond P Stowe; M Kristen Peek; Norma A Perez; Deborah L Yetman; Malcolm P Cutchin; James S Goodwin
Journal:  J Epidemiol Community Health       Date:  2009-10-12       Impact factor: 3.710

3.  EBV reactivation serological profile in primary Sjögren's syndrome: an underlying trigger of active articular involvement?

Authors:  Sandra Gofinet Pasoto; Renato Romera Natalino; Henrique Pires Chakkour; Vilma Dos Santos Trindade Viana; Cleonice Bueno; Elaine Pires Leon; Margarete Borges Gualhardo Vendramini; Mauricio Levy Neto; Eloisa Bonfa
Journal:  Rheumatol Int       Date:  2012-09-06       Impact factor: 2.631

4.  A large-scale seroprevalence of Epstein-Barr virus in Taiwan.

Authors:  Chao-Yu Chen; Kuan-Ying A Huang; Jen-Hsiang Shen; Kuo-Chien Tsao; Yhu-Chering Huang
Journal:  PLoS One       Date:  2015-01-23       Impact factor: 3.240

5.  Seroprevalence of IgA anti Epstein-Barr virus is high among family members of nasopharyngeal cancer patients and individuals presenting with chronic complaints in head and neck area.

Authors:  Susanna Hilda Hutajulu; Jajah Fachiroh; Gabriella Argy; Sagung Rai Indrasari; Luh Putu Lusy Indrawati; Dewi Kartikawati Paramita; Theodola Baning Rahayu Jati; Jaap M Middeldorp
Journal:  PLoS One       Date:  2017-08-11       Impact factor: 3.240

Review 6.  A Case of Double Standard: Sex Differences in Multiple Sclerosis Risk Factors.

Authors:  Benedetta Angeloni; Rachele Bigi; Gianmarco Bellucci; Rosella Mechelli; Chiara Ballerini; Carmela Romano; Emanuele Morena; Giulia Pellicciari; Roberta Reniè; Virginia Rinaldi; Maria Chiara Buscarinu; Silvia Romano; Giovanni Ristori; Marco Salvetti
Journal:  Int J Mol Sci       Date:  2021-04-02       Impact factor: 5.923

Review 7.  Sex-Specific Environmental Impacts on Initiation and Progression of Multiple Sclerosis.

Authors:  Jonatan Leffler; Stephanie Trend; Shelley Gorman; Prue H Hart
Journal:  Front Neurol       Date:  2022-02-03       Impact factor: 4.003

Review 8.  The X-files in immunity: sex-based differences predispose immune responses.

Authors:  Eleanor N Fish
Journal:  Nat Rev Immunol       Date:  2008-09       Impact factor: 53.106

9.  Gender and the Sex Hormone Estradiol Affect Multiple Sclerosis Risk Gene Expression in Epstein-Barr Virus-Infected B Cells.

Authors:  Jeremy T Keane; Ali Afrasiabi; Stephen D Schibeci; Nicole Fewings; Grant P Parnell; Sanjay Swaminathan; David R Booth
Journal:  Front Immunol       Date:  2021-09-08       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.